batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Xospata keeps failing in the first line 10 March 2026 Tazverik safety scare puts pressure on Oric 9 March 2026 Fifth subcutaneous PD-1 could be Junshi's 9 March 2026 Adjuvant Enhertu gets priority 9 March 2026 Bristol gets another celmod victory 9 March 2026 ESGO 2026 – regulators don’t buy Merck’s all-comers claim 2 March 2026 Hernexeos beats Hyrnuo to the front line 27 February 2026 Revolution spreads its PRMT5 bet 26 February 2026 Load More